If African-American enrollment in clinical trials continues to be low, we will continue to see disparities in the treatment of diseases as well as unanswered questions as to why the African American population fares less than others when diagnosed with certain diseases such as cancer and diabetes??? says Dr. Cedric Bright, President of the National Medical Association.